|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Embryonic Stem Cells |
1 Departments of Philosophy and Biology, Wesleyan University, Middletown, Connecticut
* To whom correspondence should be addressed. E-mail: lgrabel{at}wesleyan.edu.
| Abstract |
|---|
Despite the identified therapeutic potential of embryonic stem cells for treating human disease and injury, a number of roadblocks, scientific and ethical, stand in the way of progress towards this goal. We identify six areas of particular interest -- tumorigenicity, animal product contamination, genetic compatibility, funding, cell type for transplantation, "embryo friendly" derivation methods and discuss avenues for moving beyond the difficulties.
Key Words. human embryonic stem cell therapy, ethics, oversight
This article has been cited by other articles:
![]() |
P. A. Schweizer, U. Krause, R. Becker, A. Seckinger, A. Bauer, C. Hardt, V. Eckstein, A. D. Ho, M. Koenen, H. A. Katus, et al. Atrial-Radiofrequency Catheter Ablation Mediated Targeting of Mesenchymal Stromal Cells Stem Cells, June 1, 2007; 25(6): 1546 - 1551. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
